JUN and urinary bladder carcinoma: Furthermore, MEK inhibitors obviated the recruitment of AP-1 subunit c-Jun, p65, and Pol II to AMP promoters, thereby demonstrating that the mediation of AP-1 is in part as a transcriptional factor of BCG-induced AMPs release in bladder cancer cells.